First chemoenzymatic synthesis of immunomodulating macrolactam pimecrolimus
The preparation of pimecrolimus, a synthetic derivative of ascomycin endowed with immunomodulatory activity, requires the selective protection of 24-hydroxy group of the ascomycin, before elaboration of the 32 one. The aim was achieved by means of two regioselective Candida antarctica lipase-catalyz...
Published in: | Tetrahedron Letters |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/2434/66629 https://doi.org/10.1016/j.tetlet.2009.05.066 |
Summary: | The preparation of pimecrolimus, a synthetic derivative of ascomycin endowed with immunomodulatory activity, requires the selective protection of 24-hydroxy group of the ascomycin, before elaboration of the 32 one. The aim was achieved by means of two regioselective Candida antarctica lipase-catalyzed steps. The structure of the new key intermediates, 24-, 32-monoacetates and 24,32-diacetate, was established by means of an unambiguous NMR study. |
---|